Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Open, Classified

Mindray BeneVision Distributed Monitoring System( DMS) 1. p/n 115-051209-00 2. p/n 115-034414-00 and 115-034413-00 when used with the following software versions: 03.04.00 04.01.00 04.03.00 04.04.00 04.04.01

FDA Recall Z-1254-2021 · Posted None

Recall StatusOpen, Classified
Product CodeMSX
Date Initiated2021-02-22
Product Quantity1938 systems

Reason for Recall

BeneVision DMS may intermittently freeze and require a manual reboot after which normal operation resumes. If a freeze occur, patients monitored on a telemetry transmitter will no longer communicate data to the BeneVision DMS

Firm Action

Mindray issued URGENT Medical Device Correction letter on February 22, 2021 via certified mail, return receipt, signature required. Letter stated reason for recall, health risk and action to take: Should the BeneVision DMS freeze, perform a reboot of the system and normal monitoring will resume. If needed, Mindrays Technical Support team can assist and may be reached at (877) 913-9663 (Option 1), Monday through Friday, 8:30am - 5:30pm ET. A configuration change will be deployed by Mindrays Service team and is anticipated to take approximately 10-15 minutes per system. A representative from Mindrays Service team will contact you to schedule the update. The FDA requests that you acknowledge receipt of this recall by completing the attached Acknowledgement and Receipt Form. Please return the form in the stamped envelope provided, or by email to [email protected].

Root Cause

Software design

Distribution Pattern

Nationwide Canada

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑